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The  objective  was  to characterise  cervical  leukocyte  populations  and  inﬂammatory  mediators  associ-
ated  with  term  and  recurrent  spontaneous  preterm  birth  (SPTB)  in pregnant  women  with  a  history  of
SPTB.  A  prospective  observational  study  was  undertaken  on  120  women  with  a history  of  SPTB. A  cyto-
brush  was  used  to sample  cells  from  the cervix  at 12–25  weeks’  gestation.  Cells  were  enumerated  and
characterised  by ﬂow  cytometry.  Cytokines  and  chemokines  were  also  measured.  Participants  were then
grouped  according  to delivery  at term  (>36 + 6 weeks),  late  SPTB  (34–36  +  6 weeks)  or early  SPTB  (<34
weeks).  Differences  in leukocyte  sub-populations,  cytokine  and  chemokine  levels  were  compared  with
outcome.  Cervical  leukocytes  comprised  up  to 60%  of  the host-derived  cells.  Most  of these  (90–100%)
were  polymorphonuclear  cells (PMN).  Most  of  the remaining  cells  were  mucosal  macrophages  express-
ing  CD68  and  CD103  in  addition  to markers  shared  with  blood-borne  monocytes.  Failure  to  detect  cervical
macrophages  in  at least  250,000  cervical  epithelial  cells  was  a feature  of  women  who  experienced  early
SPTB (6  out  of  6 cases,  95%  CI 61–100%)  compared  with  34%  (30  out  of 88  cases,  95%  CI 25–43%,  P  <  0.001)
of  women  delivering  after  34 weeks.  CCL2  (MCP-1)  was also low  in  SPTB  before  34  weeks and  levels
above  75  ng/g  and/or  the  presence  of  macrophages  increased  the speciﬁcity  for birth  after  34 weeks  from
66% to 82%  (55  out of  67  cases,  95%  CI 73–91%).  Absence  of cervical  macrophages  and low  CCL2  may be
features  of pregnancies  at risk  of  early  SPTB.
© 2015  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is an  open  access  article  under  the  CC  BY. Introduction
Preterm birth (birth before 37 weeks’ gestation) affects 5–13%
f births in the developed world and the incidence is increasing
Chang et al., 2013). While factors such as an increase in multiple
regnancies and iatrogenic preterm birth contribute to the overall
ncrease, most spontaneous preterm births (SPTB) remain unex-
lained. A better understanding of the pathways leading to SPTB
nd the use of this knowledge to identify women who  would most
eneﬁt from treatment strategies to prolong gestation would con-
ribute to the alleviation of this societal and healthcare burden.
We and others have compared placentas and fetal membranes
elivered at term and preterm for the presence of bacteria using
ighly sensitive methods (Doyle et al., 2014; Jones et al., 2009; Kim
t al., 2009). Although bacteria, most commonly Lactobacilli spp.,
an be found in the placenta and fetal membranes of term deliver-
Abbreviations: SPTB, spontaneous preterm birth; LMC, late miscarriage; PMN,
olymorphonuclear cells.
∗ Corresponding author. Fax: +44 2079052882.
E-mail address: patricia.hunter@ucl.ac.uk (P.J. Hunter).
ttp://dx.doi.org/10.1016/j.jri.2015.11.002
165-0378/© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access license  (http://creativecommons.org/licenses/by/4.0/).
ies, spontaneous preterm deliveries are distinguished by the much
higher frequency of colonisation and by the nature of the species
identiﬁed. Bacteria can infect and sometimes cross the placenta via
the maternal circulation, but in most cases bacteria are thought to
access the foetus by ascending the cervical canal, causing chorioam-
nionitis (inﬁltration of the membranes by polymorphonuclear cells
[PMN]) and colonising the amniotic ﬂuid (DiGiulio et al., 2008;
Goldenberg et al., 2000; Kim et al., 2009). As the infection spreads,
the normally anti-inﬂammatory uterine environment may  undergo
a transformation and begin to respond to bacterial invasion with
inﬂammation; cytokine and chemokine production and the inﬁl-
tration of both fetal and maternal PMN. Levels of IL-8, IL-6, IL1,
TNF and the CC type chemokines in maternal serum and cervi-
cal secretions increase concomitantly with both term and preterm
cervical ripening (Dubicke et al., 2010; Törnblom et al., 2005), pre-
labour membrane rupture (Holst et al., 2007; Luo et al., 2000) and
contractions (Arntzen et al., 1997; Hebisch et al., 2004; Shobokshi
and Shaarawy, 2002; Tency, 2014).Ascending infection is normally prevented by formidable
defence mechanisms that work together to create an environment
within the cervical canal that is hostile to bacteria. Anti-microbial
peptides (defensins), secreted antibodies and the thick, negatively
article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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harged mucus contribute to form an effective antimicrobial shield
Cole, 2006). During pregnancy the mucus plug not only provides
 physical barrier, but also retains antibodies and defensins in its
atrix, thus enhancing maternal protection from infection (Hein
t al., 2002).
In view of this array of antimicrobial defences, it is unclear
hy in some women bacteria still gain access to the feto-placental
nit. To understand why this occurs, we have characterised the
eukocyte populations found at the distal cervix and endocervical
anal and measured the cytokines and chemokines that mediate
eukocyte recruitment. We  have adapted a previously described
ethod of sampling the cervix (Prakash et al., 2001; Whitworth
t al., 2007) using a cytobrush and extensively characterised the
eukocyte populations using ﬂow cytometry. Our hypothesis is that
ome insufﬁciency of leukocyte recruitment to the cervix may  be
ssociated with a recurrence of SPTB in women with a history of
PTB.
. Methods
.1. Patients and samples
Pregnant women were recruited over a period of 18 months
rom a specialist antenatal prematurity clinic at University Col-
ege London Hospital at their ﬁrst presentation to the clinic. The
tudy was approved by the Harrow Local Research Ethics Com-
ittee (09/H0714/66) and has a portfolio (13818) in the NIHR UK
linical Research Network. Women  with a history of at least one
pontaneous late miscarriage (spontaneous labour with delivery
etween 16 + 0 and 23 + 6 weeks’ gestation) or live birth before
6 + 6 weeks’ gestation following spontaneous labour or preterm
re-labour rupture of membranes (PPROM) were invited to par-
icipate. Prospective exclusion criteria included previous surgery
o the cervix, uterine malformation, multiple pregnancy or a his-
ory of iatrogenic preterm delivery. Women  were also excluded
f they had already received antibiotics, progesterone or cervical
erclage in their current pregnancy. Women  who received antibi-
tics, progesterone or ultrasound-indicated or elective cervical
erclage placement subsequent to study entry were not excluded.
reatments were noted and reported in Table 1. Written informed
onsent was obtained for each participant.
At presentation to the Preterm Birth Clinic, a history was  taken
nd a urine sample was screened for asymptomatic bacteriuria.
omen  meeting the criteria for study entry were given information
n the study and invited to participate. A sterile speculum exami-
ation was performed by a provider with training in Genitourinary
edicine and high vaginal swabs were taken and tested for bacte-
ial vaginosis (growth of anaerobic bacteria), Trichomonas vaginalis,
onococcus, chlamydia, group B Streptococcus and candidiasis. For
omen who had consented to participate in the study, a cervical
ytobrush (Cellpath, Powys, UK) was then gently rotated 360◦ in the
ervical canal. The brush was placed in a 15-mL tube containing
 mL  of cold phosphate buffered saline (PBS) supplemented with
 mmol  glutamine and pen/strep and kept at 4 ◦C for up to 4 h while
waiting preparation for ﬂow cytometry.
Fortnightly cervical length measurements were carried out
sing transvaginal ultrasound on all women attending the Preterm
irth Clinic until 22 weeks’ gestation, when vaginal fetal ﬁbronectin
as measured. Data on cervical length and fetal ﬁbronectin for
omen in the study are reported in Table 1..2. Sample processing
Samples were prepared according to Prakash et al. (2001).
rieﬂy, the 15-mL tube containing the cytobrush was  vortexed fore Immunology 113 (2016) 42–49 43
1 min, then centrifuged at 200 × g for 10 min  at 4 ◦C. The super-
natant was  aliquoted and saved at −80 ◦C. The cell pellet was
resuspended in 3 mL  PBS containing 1% fetal calf serum and passed
through a 70-m ﬁlter. Cells in suspension were observed and
counted using microscopy. The cells were then centrifuged again
at 200 × g and resuspended at 107/mL. 30 L or 300,000 cells were
subjected to analysis with groups of antibodies against surface pro-
teins using ﬂow cytometry.
2.3. Analysis by ﬂow cytometry
The phenotype of cells collected on the cervical brushes was
determined using ﬂow cytometry. Squamous epithelial cells and
dead leukocytes absorbed 4′,6-diamino-2-phenylindole (DAPI).
Cells that excluded DAPI were examined using directly labelled
monoclonal antibodies against the following human proteins:
CD45-FITC and CD16-PerCPCy5.5 from BD Biosciences (Franklin
Lakes, NJ, USA), CD163-PE, CD11b-PE, CD20-PE, CD14-PerCPCy5.5,
HLA-DR-PECy7, CD19-PECy7, CD27-PECy7, CCR7-PECy7, CD11b-
APC (activation epitope CBRM1/5) and CD16-APC from eBioscience
(San Diego, CA, USA); CD235a-PE, CD68-PE, CD66b-PE, CD103-PE,
CD11c-PE, CX3CR1-PE, CCR2-PerCPCy5.5, CD3-PECy7, CCR1-APC,
CD4-APC, CD33-APC and CD64-APC from Biolegend (San Diego, CA,
USA). Flow cytometric data were collected on an LSRII (BD Bio-
sciences). A minimum of 300,000 events were collected for each
group of antibodies so that even a leukocyte population consisting
of 0.01% of the total host-derived cells could be reliably detected.
Data were analysed using FlowJo 9.6.4 (TreeStar, Ashland, OR, USA).
2.4. Protein quantiﬁcation
Total protein content of cervical brush supernatants was deter-
mined by mixing 25 L with 225 L of Bradford Reagent (Sigma) in
duplicate and comparing the OD at 610 nm with a set of standards
containing a known quantity of bovine serum albumin (Sigma). IL-
8 was detected using the Ready Set Go 2nd generation ELISA kit
from eBioscience. IL-1, IL-6, TNF, IFN,  IL-10, CCL2, CCL3 and
CCL4 were detected as a multiplex using the V-plex system from
Mesoscale Discovery (MSD, Rockville, MD,  USA).
2.5. Histological chorioamnionitis
Routine examination for histological chorioamnionitis was
performed on the extraembryonic material from all births that
occurred up to 34 weeks.
2.6. Statistics
Statistical analyses were performed using Statistical Package for
the Social Sciences version 18 (SPSS, Chicago, IL, USA) or GraphPad
Prism 5 (San Diego, CA, USA). Conﬁdence intervals for sample sizes
<15 were calculated using the method of Altman et al. (2000) A
Mann–Whitney U test was performed to calculate statistical signif-
icance between groups. Samples that had no detectable cytokine or
chemokine were given the value of the detection limit (12.5 pg/mL
for CCL3 and 3 pg/mL for CCL4).
3. Results
3.1. Clinical characteristics of the cohort
Samples were collected from 120 participants between 12 and
25 weeks’ gestation, but most (85%) were obtained before 18 weeks.
Samples contaminated with blood were excluded (n = 14, 12%), as
were those with fewer than 250,000 cells (n = 7, 6%). There was good
agreement between the detection of blood by visual inspection and
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Table 1
Summary of the clinical characteristics of participants.
Term (>36 + 6 weeks) Late preterm (34–36 + 6 weeks) Early preterm (<34 weeks)
(n  = 76) (n = 12) (n = 6)
Age (years, mean ± SD) 32.5 ± 5.5 34.4 ± 5.1 32.5 ± 4.6
BMI  at ∼10 weeks (mean ± SD) 26.4 ± 5.7 26.0 ± 4.8 26.2 ± 6.0
Smoked during pregnancy (n, %) 5, 6.6% 0, 0% 1, 17%
Ethnicity (n, %)
White 46, 61% 7, 58% 5, 83%
Afro-Caribbean 17, 22% 2, 17% 1, 17%
Asian  13, 17% 3, 25% 0, 0%
History (n, %)
Previous SPTB <34 weeksa 36, 47% 3, 25% 4, 67%
Previous SPTB ≥34 weeksb 9, 12% 7, 58% 1, 17%
Previous LMC  31, 41% 2, 17% 1, 17%
Sample donated
12–20 weeks (n, %) 66, 87% 9, 75% 5, 83%
Progesterone 0, 0% 0, 0% 2, 33%
Ultrasound indicated cerclage
(Cervix <25 mm;  n, %) 2, 2.6% 5, 42% 1, 17%
Elective cerclage (n, %) 12, 16% 0, 0% 3, 50%
Cervico-vaginal fetal ﬁbronectin
>50 ng/mL detected at 22–24
weeks (n, %) 6, 7.9% 5, 42% 3, 50%
Shortest cervical length (mm,  mean ± SD) 29.5 ± 4.4 24.8 ± 6.8 26.5 ± 8.0
Positive result in infection screen
(n, %)c 29, 38% 2, 17% 1, 17%
SPTB spontaneous preterm birth, LMC  late miscarriage (16–23 + 6 weeks).
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Ca One or more SPTB <34 weeks. These women may  also have had LMC or SPTB ≥3
b One or more SPTB ≥34 weeks. These women may  also have had LMC.
c Infections screened for bacterial vaginosis, Trichomonas vaginalis, gonococcus, c
he presence of CD235a-expressing cells detected by ﬂow cytom-
try. Blood contamination was more common at the beginning of
he study and reduced with experience in sampling. Insufﬁcient
ell numbers were an unintended consequence of avoiding cervi-
al bleeding. In total, 99 samples were analysed by ﬂow cytometry,
ut 5 women were subsequently excluded, leaving 94 available for
nalysis (2 women had iatrogenic preterm births, one woman had
n early miscarriage, one woman withdrew from the study and one
oman was lost to follow-up). Table 1 shows the clinical charac-
eristics of the participants at the time of sample donation. Among
he three outcome categories (≥37 weeks, 34–36 + 6 weeks and
34 weeks) there were no signiﬁcant differences in the mean age,
MI, smoking during pregnancy, ethnic background or proportion
f samples donated before 20 weeks. The proportions of partic-
pants with a history of at least one live birth before 34 weeks or
ho received progesterone, elective cerclage, ultrasound-indicated
erclage owing to a cervix of <25 mm and/or had >50 ng/mL cervico-
aginal fetal ﬁbronectin at 22–24 weeks were increased in the
roups of women who had a preterm birth (Table 1), as would
e expected using current risk stratiﬁcation algorithms. Clinical
haracteristics of the participants whose samples were excluded
ecause of blood contamination or insufﬁcient cell numbers are
iven in Supplementary Tables 1 and 2.
.2. Surface protein expression by cervical leukocytes
In all samples, squamous epithelial cells could be identiﬁed by
ow cytometry as those with variable sizes and high granularity
Fig. 1A). In most of the samples, a population of CD45+ cells (leuko-
ytes) was also detected (Figs. 1 and 2A and 2B). When present,
he majority of leukocytes (90–100%) were polymorphonuclear
PMN), identiﬁed by the surface expression of CD13, CD16, CD66b,
D11c and the activated form of CD11b (Fig. 1C). The remain-
ng population largely consisted of cells of the monocyte lineage,
niformly expressing HLA-DR, CD11b, CD11c, CD13, CD14, CD33,
D68, CD163CX3CR1 and a range of CD103 (integrin E; Fig. 1C).ks.
dia, group B Streptococcus, candidiasis and asymptomatic bacteriuria.
Consistently high expression of CD68 on all CD14+ cells from these
samples led us to conclude that these cells are macrophages. No
natural killer or B cells and very few T cells (<0.05% of leukocytes
and only in a minority of samples) were detected in the cervical
brushes.
3.3. Prospective study
We  compared data on the presence of cervical leukocytes in the
late ﬁrst and second trimester between the women who subse-
quently delivered at term (n = 76) and the women who experienced
recurrent SPTB, either early (<34 weeks; n = 6) or late (34–36 + 6
weeks; n = 12). None of the participants had a late miscarriage. Fig. 2
contains representative ﬂow cytometric plots of samples in which
leukocytes were detected (Fig. 2A) or were undetectable (Fig. 2C).
Fig. 2D plots for each participant the proportion of host-derived
cells with a leukocyte phenotype (CD45+). Table 2 summarises the
leukocyte subset detection rates for each participant group. Leuko-
cytes were detected in 2 out of 6 (33%, 95% CI 10–70%) cytobrush
samples from participants who delivered at <34 weeks compared
with 7 out of 12 (58%, 95% CI 32–81%) of the late SPTB and 53 out of
76 (70%, 95% CI 60–80%) of the participants who  delivered at term.
We then compared the distribution of cervical leukocyte sub-
sets among outcome groups. None of the participants who gave
birth before 34 weeks had any detectable macrophages (0%, 95% CI
0–39%; Fig. 2E and Table 2) compared with 7 out of 12 (58%, 95%
CI 32–81%, P < 0.05) of the late SPTB and 51 out of 76 (67%, 95% CI
57–77%, P < 0.001) of the participants who  delivered at term. Histo-
logical examination of the placenta and membranes was  performed
on all early SPTB (before 34 weeks); in 5 out of 6 cases there was
evidence of chorioamnionitis.
Cervical leukocyte distribution was compared with cervical
length and cervico-vaginal fetal ﬁbronectin at 22–24 weeks. Whilst
the number of participants who  experienced a recurrence of SPTB
was low, of the 6 participants who received ultrasound-indicated
cerclage because of the early detection of a short cervix (<25 mm), 5
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Fig. 1. Human cervical leukocytes obtained from cytobrushes consist of two  subsets of phagocytic cells, as detected using ﬂow cytometry. Cells in suspension were stained
with  the antibodies against the indicated surface proteins. (A) Leukocytes could be distinguished from epithelial cells based on size (FSC) and granularity (SSC). (B) Selected
events  in (A) express CD45. (C) Live cells (those that exclude 4′ ,6-diamino-2-phenylindole [DAPI]) selected in (B) are either PMN  (CD13+, CD16+, CD66b+) or macrophages
(CD13+, CD14+, CD68+, HLA-DR+, CD33+, CD163+, CX3CR1+, CD103 variable). Both cell types express CD11c and the activated form of CD11b. Grey histograms represent
isotype controls.
Table 2
Summary of the association of detected leukocyte subsets and CCL2 with SPTB.
Term (>36 + 6 weeks) Late preterm
(34–36 + 6 weeks)
Early preterm
(<34 weeks)
PMN  (CD45+CD13+
CD16+CD66b+)
53/76 (70%) 7/12 (58%) 2/6 (33%)
Macrophages (CD45+
CD13+CD14+
CD68+HLADR+)
51/76 (67%) 7/12 (58%) 0/6 (0%)
CCL2  (>75 ng/g total
protein)
26/58 (45%) 5/9 (56%) 0/5 (0%)
Macrophages or CCL2 46/58 (79%) 9/9 (100%) 0/5 (0%)
P
h
d
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t
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t
w(>75 ng/g total protein)
MN: Polymorphonuclear cells.
ad >50 ng/mL fetal ﬁbronectin at 22–24 weeks. Of these, 4 had no
etectable cervical leukocytes. Of the 14 participants who  received
erclage and gave birth at term, only 2 lacked cervical leukocytes
nd these were not the same 2 participants who had short cervices.
We measured IL-8, IL-6, IL1,  IL-10, IFN and TNF in addition
o the CC-type chemokines that attract CCR1- and CCR2-expressing
ells (CCL2, CCL3 and CCL4) in cervical brush supernatants of 72 of
he 94 participants in the study. IFN, TNF and IL-10 were detected
n less than 20% of samples and only in small amounts. Detection
f these cytokines tended to occur in samples with a large amount
f protein, the presence of T cells or high levels of other cytokines
data not shown). All of the proteins assayed with the exception
f CCL2 had reduced levels in samples with no leukocytes, even
hough the total protein was equivalent between those with and
ithout leukocytes (Fig. 3B). In contrast, CCL2 was reduced in theearly preterm group compared with the late preterm and term
groups (Fig. 3A). Thus, CCL2 above 75 ng/g and/or the presence
of macrophages increased the speciﬁcity for birth after 34 weeks
to 82% (95% CI 73–91%) compared with 66% (95% CI 57–75%) for
macrophages alone. Even though protein content in the cervical
washes increased with advancing gestation, the levels of measured
cytokines and chemokines remained the same per gram of total
protein. Of all factors measured, IL-6 had the strongest correlation
with leukocyte proportions of the total host-derived cell content
(r2 = 0.49, P < 0.001, data not shown).
The observed cervical immune phenotype of undetectable
macrophages and low CCL2 was tested against the current factors
used in early risk stratiﬁcation (previous SPTB <34 weeks or cervical
length <25 mm).  We  chose 18 weeks as the cut-off for the detec-
tion of a short cervix as we are aiming to develop an algorithm that
46 P.J. Hunter et al. / Journal of Reproductive Immunology 113 (2016) 42–49
Fig. 2. Relationship between cervical cellular phenotype and preterm birth. (A–C) Examples of three different cellular phenotypes from cervical brushes. (A) Leukocyte
population consisting of 9% macrophages (CD13+, CD14+) and 91% PMN  (CD13+, CD14−). (B) Leukocyte population consisting solely of PMN. (C) No leukocytes detected. (D)
D s who
( xpres
w
c
f
c
C
tot  plot showing proportion of host-derived cells expressing CD45 from participant
22–33  + 6 weeks; n = 6). E. Dot plot showing the proportion of host-derived cells e
ho  received cerclage after sample donation. Horizontal lines indicate means.
ould potentially inform decisions ahead of the optimal window
or treatment with progesterone (Romero et al., 2014), cervical cer-
lage (Romero et al., 2006) and antibiotics (Joergensen et al., 2014).
ervical immune phenotype predicted SPTB before 34 weeks better
han previous SPTB <34 weeks or short cervix because of its abil- delivered at term (n = 76), late preterm (34–36 + 6 weeks; n = 12) and early preterm
sing CD14 from the same participants as in (D). Open circles indicate participants
ity to rule out the large number of participants who  had a history
of SPTB <34 weeks, but who lacked the high-risk immune pheno-
type (Table 3). There was no difference between the two models
for predicting overall preterm birth.
P.J. Hunter et al. / Journal of Reproductive Immunology 113 (2016) 42–49 47
Fig. 3. Differences in total protein, cytokine and chemokine levels in the cervical brush washes of different participant groups (n = 71). (A) Participants were grouped according
to  birth outcome. (B) Participants were grouped according to the presence or absence of cervical leukocytes. (C) Participants were grouped according to the stage of gestation
when  the sample was taken. Total protein is shown as mean with standard error. Cytokines and chemokines are shown as dots with horizontal lines indicating means. The
limits  of detection for CCL3 and CCL4 were 12.5 pg/mL and 3 pg/mL respectively. Samples with undetectable amounts of these cytokines were given the value of the detection
limit.  * = P < 0.05; ** = P < 0.01; *** = P < 0.001 between groups using the Mann–Whitney U test.
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Table 3
Comparison of likelihood ratios (LR+) for predicting SPTB based on history and cervical length versus cervical immune phenotype.
LR+ for SPTB <37 weeks LR+ for SPTB + <34 weeks
(1) Previous SPTB <34 or
cervical length <25 mm
before 18 weeks
1.1 (95% CI 0.71–1.8) 1.7 (95% CI 1.1–2.6)
(2)  Undetectable cervical
macrophages and
CCL2 <75 ng/g
1.7 (95% CI 0.73–4.1) 5.6 (95% CI 3.3–9.3)*
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* P < 0.05 in comparison with (1).
. Discussion
This study provides a detailed assessment of cervical cellular
mmunity in pregnant women  with a history of SPTB. The women
estined to deliver before 34 weeks’ gestation had an absence of
ervical macrophages and low levels of CCL2 in cervical mucus early
n pregnancy. The paucity of these cervical antimicrobial compo-
ents may  have predisposed these women to ascending bacterial
ranslocation and the chorioamnionitis that was apparent in the
xtraembryonic membranes in 5 out of 6 cases.
We found that the dominant population of cervical leuko-
ytes are polymorphonuclear cells, probably neutrophils, with
 minor population of macrophages. The ﬁnding that PMN  and
acrophages are the most prevalent cervical leukocytes is in agree-
ent with a previous study in which immunohistochemistry was
erformed to identify and count cervical leukocytes (Whitworth
t al., 2007). Whitworth et al. also reported low numbers of
acrophages in cervical brush samples where the delivery was
efore 35 weeks. We rarely detected lymphocytes, although they
ave been reported in women attending a genitourinary infec-
ion clinic (Prakash et al., 2001) and in cervices of women  with
ervicitis, either clinically apparent or sub-clinical (Ibana et al.,
012; Ling et al., 2011). A systematic analysis of cervical leuko-
ytes from non-pregnant women has not as yet been performed;
owever, it is interesting to note that routine microscopic analysis
f Pap-stained cells from non-pregnant women reveals cells with
etralobular nuclei (neutrophils) intermingling with squamous
pithelial cells. Only occasionally are cells with large vacuoles char-
cteristic of macrophages, apparently suggesting that increased
ervical macrophages might be a feature of pregnancy.
The only difference detected between the surface proteins on
lood-borne monocytes and cervical macrophages was the expres-
ion of the adhesion molecules, CD103 (integrin E) and CD68. As
uch it is tempting to assume that cervical leukocytes are derived
redominantly from blood-borne precursors that exit the circula-
ion and migrate through the epithelium. However, recent evidence
uggests that tissue-resident myeloid cells such as Kupffer cells in
he liver, Langerhans cells in the skin and microglia in the brain
ight be derived from progenitors that predate haematopoietic
tem cells during embryonic development (Schulz et al., 2012).
hese long-term resident cells have been shown to respond to
amage to their local environment and participate in its repair in
esponse to inﬂammatory signals (Davies et al., 2013). As human
issue-resident myeloid cells are indistinguishable from blood
onocyte-derived macrophages, it is not possible to ascertain
he source of cervical macrophages at present. It is possible that
oth resident and blood-derived cells contribute to the cervical
acrophage population through the continuous low-grade inﬂam-
atory environment maintained by low levels of cytokines and
hemokines in the cervix.
In this report we have described a unique phenotype of a sub-
et of women who are at a heightened risk of preterm birth. This
henotype is characterised by the absence of phagocytic leuko-
ytes, particularly macrophages, and low levels of secreted CCL2.9.2 (95% CI 3.8–22)*
This subset overlaps with approximately 60% of the women who
receive cerclage because they have a short cervix (<25 mm)  before
18 weeks and/or have >50 ng/mL cervico-vaginal fetal ﬁbronectin at
22–24 weeks. Importantly, this subset also includes women whose
preterm delivery was not predicted by current clinical screening
protocols. It does not include women  who  deliver at 34–36 + 6
weeks with no other predictors and average levels of cervical
cytokines and chemokines. SPTB in this group remains unexplained.
Only levels of CCL2 above 75 ng/g total protein added further speci-
ﬁcity for birth after 34 weeks among women who lacked cervical
macrophages. Both CCL2 and IL-8 are produced by cervical epithe-
lial cells (Kleine-Lowinski et al., 2003) and both have been the
target of disruption by invading pathogens at the genital and other
mucosal sites (Darveau et al., 1998; Kleine-Lowinski et al., 2003).
IL-6 levels had the strongest correlation with the leukocyte propor-
tion of the host-derived cells, suggesting that IL-6 might be secreted
from the leukocytes themselves. This correlation was surprising as
IL-6 is highly variable among individuals in serum (Christ-Crain and
Opal, 2010).
It is of interest that the high-risk immune phenotype was
detected in 20% of participants who delivered at term. This high-
lights the fact that the anti-microbial barrier function of the cervical
canal is likely to depend on a number of different but comple-
mentary factors (Cole, 2006; Mestecky et al., 2005). The control
group (i.e. those delivering at term) in this study is not necessar-
ily representative of the normal pregnant population as they were
being seen in a specialised preterm birth clinic because of a history
of SPTB. It is necessary to replicate this study in women  with no
identiﬁable risks.
In conclusion, we  propose that bacterial invasion of the
intrauterine space during pregnancy and the ensuing inﬂammatory
response that occurs with the onset of preterm labour may be pre-
ceded by a period of inadequate cervical immune defence against
ascending infection. The presence of phagocytic leukocytes at the
distal cervix and endocervical canal and the chemokines that sup-
port their migration are features of pregnancies that are likely to
go to term, and failure to detect even a small number of leukocytes
by highly sensitive ﬂow cytometric methods is a marker of height-
ened risk of preterm birth. Furthermore, this phenotype is evident
as early as 12 weeks and offers signiﬁcant improvement in current
early risk stratiﬁcation for SPTB, thus creating a gestational win-
dow of opportunity for interventions that could potentially prolong
pregnancy. Our observations indicate that cervical leukocytes and
particularly macrophages may play a critical role in cervical immu-
nity and speciﬁcally in preventing microbial translocation to the
feto-placental unit. It may  therefore be possible to identify mothers
at high risk of SPTB in which microbes are the probable trigger.
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